Antony Pfaffle, Interim Chief Medical Officer at CorMedix Inc. (CRMD), sold 125 shares at $0.92 ($115) on 2013-09-24, disclosed to the SEC on 2013-09-30.
Open-market sale of $115 CRMD by Interim Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CRMD | SELL | 2016-06-22 | $127K | — | Filing → |
| CRMD | SELL | 2016-06-16 | $11K | — | Filing → |
| CRMD | SELL | 2016-06-14 | $12K | — | Filing → |